“Manipal Health Enterprises is set to become debt-free using IPO proceeds, a significant achievement in the healthcare segment, which could drive the stock higher in coming sessions. Low-risk investors should book profits, while high-risk investors can hold with a trailing stop-loss at the issue price of ₹590, awaiting their target levels.”